Upgrade to SI Premium - Free Trial

Vertex Pharma (VRTX)

546.12 -11.84 (2.12%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/9/26)

Latest Headlines

Vortex Energy Announces Plans for Ground Gravity Survey at the Robinsons River Salt Project September 3, 2026 8:00 AM - Globe NewsWire Morgan Stanley Resumes Vertex (VRTX) at Overweight September 1, 2026 4:48 PM - StreetInsider Goldman Sachs refreshes conviction lists on both sides of the Atlantic September 1, 2026 1:41 PM - StreetInsider Goldman Sachs Adjust Monthly US Director's Cut List September 1, 2026 5:31 AM - StreetInsider Form 144 VERTEX PHARMACEUTICALS Filed by: SACHS BRUCE I August 27, 2026 4:47 PM - SEC Filing Vertex to Participate in Upcoming September Investor Conferences August 26, 2026 4:00 PM - BizWire Vortex Energy Announces Final Ambient Noise Tomography Results for the Robinsons River Salt Project August 18, 2026 8:00 AM - Globe NewsWire Vortex Energy Engages Market Maker August 17, 2026 8:01 AM - Globe NewsWire RBC Capital on Vertex (VRTX): 'SION Overhang Cleared; We Would Remain Buyers' August 12, 2026 8:50 AM - StreetInsider Bernstein SocGen Reiterates Outperform Rating on Vertex (VRTX) August 11, 2026 9:38 AM - StreetInsider Vertex Pharma (VRTX) Added to BofA US 1 List August 11, 2026 5:28 AM - StreetInsider Vertex (VRTX) PT Raised to $562 at Wolfe Research August 10, 2026 12:24 PM - StreetInsider Vertex stock jumps as rival cystic fibrosis drug fails trial August 10, 2026 10:01 AM - StreetInsider BMO Capital Reiterates Outperform Rating on Vertex (VRTX) After Rival Fails August 10, 2026 9:58 AM - StreetInsider Morgan Stanley tracks US drug market prescriptions for week ending July 31 August 7, 2026 12:04 PM - StreetInsider Vortex Energy Receives Final Technical Study Results for the Robinsons River Salt Project August 6, 2026 8:00 AM - Globe NewsWire Vertex (VRTX) PT Raised to $617 at Barclays August 5, 2026 4:30 AM - StreetInsider Form 10-Q VERTEX PHARMACEUTICALS For: Jun 30 August 4, 2026 4:09 PM - SEC Filing Vertex (VRTX) PT Raised to $500 at Stifel August 4, 2026 8:49 AM - StreetInsider Vertex (VRTX) PT Raised to $550 at TD Cowen August 4, 2026 8:12 AM - StreetInsider Vertex (VRTX) PT Raised to $595 at Cantor Fitzgerald on Uniquely Attractive Optionality August 4, 2026 7:59 AM - StreetInsider Vertex (VRTX) PT Lowered to $570 at RBC Capital August 4, 2026 7:05 AM - StreetInsider Vertex (VRTX) PT Raised to $442 at Canaccord August 4, 2026 6:44 AM - StreetInsider Form 8-K VERTEX PHARMACEUTICALS For: Aug 03 August 3, 2026 4:10 PM - SEC Filing Crinetics Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update August 3, 2026 4:05 PM - StreetInsider Vertex Pharma (VRTX) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY26 Revenue Guidance August 3, 2026 4:02 PM - StreetInsider Vertex Reports Second Quarter 2026 Financial Results August 3, 2026 4:01 PM - BizWire AbCellera and Vertex team up on T-cell engager drugs for autoimmune July 29, 2026 7:00 AM - StreetInsider AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions July 29, 2026 7:00 AM - BizWire Vortex Energy Corp. Announces Marketing Program July 24, 2026 5:00 PM - Globe NewsWire Form 4 VERTEX PHARMACEUTICALS For: Jul 21 Filed by: Tatsis Ourania July 23, 2026 4:16 PM - SEC Filing Form 4 VERTEX PHARMACEUTICALS For: Jul 21 Filed by: Sachdev Amit July 23, 2026 4:13 PM - SEC Filing Form 4 VERTEX PHARMACEUTICALS For: Jul 15 Filed by: SACHS BRUCE I July 17, 2026 4:07 PM - SEC Filing Form 4 VERTEX PHARMACEUTICALS For: Jul 15 Filed by: Garber Alan M July 17, 2026 4:06 PM - SEC Filing Vortex Energy Provides Corporate Update on Robinsons River Salt Project Technical Study July 16, 2026 8:00 AM - Globe NewsWire Vertex (VRTX) PT Raised to $560 at Truist Securities July 13, 2026 7:08 AM - StreetInsider Stifel Downgrades Crinetics (CRNX) to Hold July 8, 2026 8:45 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Vertex (VRTX) July 8, 2026 6:40 AM - StreetInsider Form 4 VERTEX PHARMACEUTICALS For: Jul 02 Filed by: Tatsis Ourania July 7, 2026 4:16 PM - SEC Filing Form 4 VERTEX PHARMACEUTICALS For: Jul 02 Filed by: McKechnie Duncan July 7, 2026 4:08 PM - SEC Filing Vertex to Announce Second Quarter 2026 Financial Results on August 3rd July 7, 2026 4:00 PM - BizWire Jones Trading Downgrades Crinetics (CRNX) to Hold July 7, 2026 9:27 AM - StreetInsider BMO Capital Reiterates Outperform Rating on Vertex (VRTX) July 7, 2026 8:49 AM - StreetInsider Vertex (VRTX) PT Raised to $570 at RBC Capital July 7, 2026 7:55 AM - StreetInsider Vertex (VRTX) Reiterated at Overweight by Cantor Fitzgerald; Crinetics Acquisition Announced July 7, 2026 7:16 AM - StreetInsider Canaccord Reiterates Hold Rating on Vertex (VRTX) July 7, 2026 6:58 AM - StreetInsider Form 8-K VERTEX PHARMACEUTICALS For: Jul 06 July 7, 2026 6:03 AM - SEC Filing Vertex Pharma (VRTX) call put ratio 1 call to 1.8 puts into acquiring Crinetics July 7, 2026 5:44 AM - StreetInsider Vertex (VRTX) PT Raised to $350 at Baird July 7, 2026 4:22 AM - StreetInsider Crinetics soars on $10B acquisition by Vertex July 6, 2026 4:14 PM - StreetInsider Form 4 VERTEX PHARMACEUTICALS For: Jul 01 Filed by: Liu Joy July 6, 2026 4:13 PM - SEC Filing Vertex to acquire Crinetics Pharmaceuticals for $10 billion July 6, 2026 4:04 PM - StreetInsider Vertex to Acquire Crinetics Pharmaceuticals July 6, 2026 4:04 PM - BizWire Vertex signs LoI with the Pan-Canadian Pharmaceutical Alliance for alyftrek for the treatment of cystic fibrosis July 6, 2026 10:25 AM - StreetInsider Form 144 VERTEX PHARMACEUTICALS Filed by: Tatsis Ourania July 2, 2026 4:31 PM - SEC Filing Form 144 VERTEX PHARMACEUTICALS Filed by: McKechnie Duncan July 2, 2026 2:16 PM - SEC Filing FDA expands Casgevy approval to children as young as 2 July 1, 2026 7:58 PM - StreetInsider Vertex Announces US FDA Approval for Expanded Use of CASGEVY® for the Treatment of People Ages 2 Years and Older With Sickle Cell Disease or Transfusion-Dependent Beta Thalassemia July 1, 2026 7:58 PM - BizWire FDA approves Casgevy gene therapy for sickle cell in children 2+ July 1, 2026 5:43 PM - StreetInsider Form 144 VERTEX PHARMACEUTICALS Filed by: Liu Joy July 1, 2026 1:00 PM - SEC Filing Form 4 VERTEX PHARMACEUTICALS For: Jun 26 Filed by: Bozic Carmen June 30, 2026 4:10 PM - SEC Filing Form 144 VERTEX PHARMACEUTICALS Filed by: Bozic Carmen June 26, 2026 9:55 AM - SEC Filing Form 4 VERTEX PHARMACEUTICALS For: Jun 18 Filed by: Bozic Carmen June 23, 2026 4:09 PM - SEC Filing Form 144 VERTEX PHARMACEUTICALS Filed by: Bozic Carmen June 18, 2026 11:33 AM - SEC Filing Form 4 VERTEX PHARMACEUTICALS For: Jun 15 Filed by: Bozic Carmen June 17, 2026 4:12 PM - SEC Filing Form 144 VERTEX PHARMACEUTICALS Filed by: Bozic Carmen June 15, 2026 3:08 PM - SEC Filing Leerink highlights drug demand rebound after Memorial Day June 12, 2026 2:42 PM - StreetInsider Vertex Presents New Data on CASGEVY®, Including First European Presentation of Data in Children Ages 5–11, at the European Hematology Association Congress and Announces Additional Global Regulatory June 11, 2026 2:01 AM - BizWire Form 4 VERTEX PHARMACEUTICALS For: Jun 05 Filed by: Bozic Carmen June 9, 2026 4:24 PM - SEC Filing Full Article List